Cream P110 contains as an active component a mitochondrial and nootropic peptide of the latest generation, which:
- maintains the mitochondrial health of neurons and promotes their proliferation;
- counteracts age-related decline in cognitive functions, including against the background of Alzheimer's disease and dementia, to a lesser extent in Parkinson's disease;
- prevents the division of defective mitochondria;
- has a positive effect on a number of classic markers of mitochondrial-neurological health: beta-amyloid deposits, mitochondrial heteroplasmy; regulates neuroprotective proteins ADAM10 and KLOTHO.
One of the fundamental metabolic signs of any chronic disease is mitochondrial heteroplasmy. As soon as defective mitochondria become more than a certain percentage of the entire pool of mitochondria, the cell loses its functions, "dies" or becomes a pre-oncocell.
Mitochondrial heteroplasmy is critical for neurons. Neurons are in complex chains of their neural connections, and the loss of neurons will mean a decrease in cognitive function in one form or another.
A number of fundamental discoveries in medicine have led to the discovery of a class of Drp1 inhibitors, and in particular, the P110 peptide:
- the membrane mitochondrial protein Drp1, critically important for the division (fission) of mitochondria, was discovered;
- it was shown how Drp1 is upregulated in pathogenic neurological and other processes;
- many Drp1 inhibitors have been found: both small molecules and peptides, like P110.
One of the main areas of application of P110 is Parkinson's disease, where the use of Drp1 inhibitors helps restore dopamine levels in the striatum and other parts of the brain.
However, in the form of our transdermal cream, this mitochondrial-nootropic peptide has shown higher efficiency in other disorders of the nervous system: Alzheimer's disease, dementia, age-related or other decline in cognitive abilities.
To enhance the effect of P110 cream, we recommend combining it with our other nootropic and mitochondrial products: creams AM-111, Digeksa, Epobis, CC-31, Mix 55, FM55#1, products with polyprenols.
Considering the evening intake, it can also be combined with products that can affect sleep, anxiety levels and recovery: Tigerin 01, BSP-4, FM55#2, Ipamorelin, Delta-son creams.
The liposomal form of P110 cream provides high bioavailability of the peptide, ease of use and ease of dosing.
Directions for use: apply the contents of three pumps of the dispenser to the head, neck, and behind the ears. It is best to use in the evening.
One bottle contains 140 pumps.
Ingredients: water, sunflower phospholipids, caprylic-capric triglycerides, neutralized carbomer, P110 peptide, ethylhexylglycerin, phenoxyethanol. Packaging: dark glass bottle with dispenser.
Storage conditions and periods: store at a temperature of 1 to 25 °C, protecting from direct sunlight. Shelf life is 2 years.